» Articles » PMID: 32295300

Natural Bioactive Compounds from Fungi As Potential Candidates for Protease Inhibitors and Immunomodulators to Apply for Coronaviruses

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2020 Apr 17
PMID 32295300
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

The inhibition of viral protease is an important target in antiviral drug discovery and development. To date, protease inhibitor drugs, especially HIV-1 protease inhibitors, have been available for human clinical use in the treatment of coronaviruses. However, these drugs can have adverse side effects and they can become ineffective due to eventual drug resistance. Thus, the search for natural bioactive compounds that were obtained from bio-resources that exert inhibitory capabilities against HIV-1 protease activity is of great interest. Fungi are a source of natural bioactive compounds that offer therapeutic potential in the prevention of viral diseases and for the improvement of human immunomodulation. Here, we made a brief review of the current findings on fungi as producers of protease inhibitors and studies on the relevant candidate fungal bioactive compounds that can offer immunomodulatory activities as potential therapeutic agents of coronaviruses in the future.

Citing Articles

Screening and identifying natural products with SARS-CoV-2 infection inhibitory activity from medicinal fungi.

Zhao S, Huang A, Zhang W, Ren L, Wang H, Wang J Biosaf Health. 2025; 6(1):12-20.

PMID: 40078308 PMC: 11894996. DOI: 10.1016/j.bsheal.2023.12.006.


Antiviral potential of ginseng: Targeting human pathogenic viruses with compounds derived from ginseng.

Huo C, Baek J, Kim K J Ginseng Res. 2025; 49(2):105-117.

PMID: 40061485 PMC: 11889387. DOI: 10.1016/j.jgr.2024.12.004.


Mushrooms in modern cosmetics: unlocking anti-aging, antioxidant, and therapeutic potential.

Rukhsar S, Usman M, Yousaf N, Murtaza G, Manzoor M, Azam M Arch Dermatol Res. 2025; 317(1):542.

PMID: 40057933 DOI: 10.1007/s00403-025-04048-7.


Phytochemical analysis of and and their therapeutic activities with special reference to COVID-19.

Rai P, Garain T, Gupta D World J Exp Med. 2024; 14(3):95512.

PMID: 39312696 PMC: 11372741. DOI: 10.5493/wjem.v14.i3.95512.


Biological Properties, Health Benefits and Semisynthetic Derivatives of Edible Astraeus Mushrooms (Diplocystidiaceae): A Comprehensive Review.

Ung A, Chen H Chem Biodivers. 2024; 21(12):e202401295.

PMID: 39177069 PMC: 11644123. DOI: 10.1002/cbdv.202401295.


References
1.
Goetz D, Choe Y, Hansell E, Chen Y, McDowell M, Jonsson C . Substrate specificity profiling and identification of a new class of inhibitor for the major protease of the SARS coronavirus. Biochemistry. 2007; 46(30):8744-52. DOI: 10.1021/bi0621415. View

2.
Hawas U, Al-Farawati R, Abou El-Kassem L, Turki A . Different Culture Metabolites of the Red Sea Fungus Fusarium equiseti Optimize the Inhibition of Hepatitis C Virus NS3/4A Protease (HCV PR). Mar Drugs. 2016; 14(10). PMC: 5082338. DOI: 10.3390/md14100190. View

3.
Vetvicka V, Vashishta A, Saraswat-Ohri S, Vetvickova J . Immunological effects of yeast- and mushroom-derived beta-glucans. J Med Food. 2008; 11(4):615-22. DOI: 10.1089/jmf.2007.0588. View

4.
Loutfy M, Blatt L, Siminovitch K, Ward S, Wolff B, Lho H . Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. JAMA. 2003; 290(24):3222-8. DOI: 10.1001/jama.290.24.3222. View

5.
Zhang S, Huang R, Li F, Wei H, Fang X, Xie X . Antiviral anthraquinones and azaphilones produced by an endophytic fungus Nigrospora sp. from Aconitum carmichaeli. Fitoterapia. 2016; 112:85-9. DOI: 10.1016/j.fitote.2016.05.013. View